Hypoactive Sexual Desire Disorder (HSDD) Treatment Market 2019-2027 – Credence Research | Industry Size, Share & Forecast

Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Is Expected To Expand At A CAGR of 5.2%

SAN JOSE, United States - August 14, 2019 /MarketersMedia/ —

The latest market report published by Credence Research, Inc. “Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market - Growth, Future Prospects, Competitive Analysis, 2019- 2027,” the global hypoactive sexual desire disorder (HSDD) treatment market is set to expand at a CAGR of 5.2% from 2019 to 2027.

Browse the full report Hypoactive Sexual Desire Disorder (HSDD) Treatment Market - Growth, Future Prospects, Competitive Analysis 2019 – 2027 at https://www.credenceresearch.com/report/hypoactive-sexual-desire-disorder-hsdd-treatment-market

Market Insights

Hypoactive sexual desire disorder (HSDD) is currently on a rise in adult women population manifested by low self confidence and less connected with their partners. Recent approval of Vyleesi will provide essential momentum for the HSDD market growth. Currently 2 drugs such as BP101 and Prasterone 6.5 mg vaginal insert are under phase 3 clinical trial are being investigated for its safety and efficacy for treatment of HSDD.

Hypoactive sexual desire disorder is the most common type of sexual dysfunction occurring in adult women worldwide manifested by lack of sex interest for a period of six months or more due to personal distress or fluctuating sex hormones during the menstrual cycle. Accurate diagnosis of the symptoms manifested in hypoactive sexual desire disorder (HSDD) is very critical to finalize the treatment regimen which is either psychotherapy or pharmacotherapy. The PLISSIT model (Permission, Limited Information, Specific Suggestions and Intensive Therapy) aids in initial screening of HSDD. Psychotherapy is suggested to patients showing positive response to counseling sessions with sex therapist.

Request Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Research Sample: https://www.credenceresearch.com/sample-request/59843

Pharmacotherapy comprises of buspirone and bupropion off label treatment for HSDD in women suffering with low libido associated with anxiety and depression. Testosterone transdermal patches are used as an off label treatment in premenopausal and postmenopausal women with HSDD. Flibanserin is currently the only drug approved by USFDA for treating HSDD in premenopausal women owing to its multifunctional serotonin agonist and antagonist pharmacodynamic profile.

North America is the largest regional segment in the hypoactive sexual desire disorder (HSDD) treatment market representing a market share of 38.5%. The chief attributing factors responsible for its supreme market growth are growing incidence of low libido in the female population owing to increasing stress in daily life and fluctuating sex hormones during the menstrual cycle. Domicile of key players such as AMAG Pharmaceutcials, Allergan, Plc., S1 Biopharma, Inc. and Sprout Pharmaceuticals, Inc. further propel the market growth in North America regional segment. Europe is placed in the second position with a market share of 32.4% primarily due to affordable reimbursement scenario for the medicines prescribed for the treatment of hypoactive sexual desire disorder (HSDD). Asia Pacific holding a market share of 15.2% will be growing at a rapid pace during the forecast period owing to rising prevalence of HSDD in working women population and developing healthcare infrastructure.

Pharmaceutical companies providing pharmacotherapy for treating hypoactive sexual desire disorder are AMAG Pharmaceutcials, Allergan, Plc., Ivix, LLX., EndoCeutics, Inc., Emotional Brain BV., S1 Biopharma, Inc. and Sprout Pharmaceutcials, Inc.

Key Market Movements:

Growing incidence of low sex drive in women population worldwide
Affordable reimbursement scenario for pharmacotherapy employed in the treatment of HSDD
Recent approval of Vyleesi and strong product pipeline will further propel the HSDD market growth during the forecast period

Request Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Research Sample: https://www.credenceresearch.com/sample-request/59843

TOC:

1. Preface...

2. Executive Summary...

3. Hypoactive Sexual Desire Disorder Treatment Market: Dynamics and Future Outlook...

Chapter 4. Global Hypoactive Sexual Desire Disorder Treatment Market, by Therapy
4.1. Overview
4.2. Buspirone
4.3. Bupropion
4.4. Testosterone
4.5. Flibanserin
4.6. Bremelanotide
4.7. Cognitive Behavior Therapy
4.8. Pipeline Analysis
4.8.1. Phase III Drug
4.8.1.1. Prasterone 6.5 mg Vaginal Insert
4.8.1.2. BP101

Chapter 5. Global Hypoactive Sexual Desire Disorder Treatment Market, by Geography
5.1. Overview
5.2. North America Hypoactive Sexual Desire Disorder Treatment Market Analysis, 2017 – 2027
5.2.1. North America Hypoactive Sexual Desire Disorder Treatment Market, by Therapy, 2017 – 2027 (US$ Mn)
5.2.2. North America Hypoactive Sexual Desire Disorder Treatment Market, by Country, 2017 – 2027 (US$ Mn)
5.2.2.1. U.S.
5.2.2.2. Canada
5.3. Europe Hypoactive Sexual Desire Disorder Treatment Market Analysis, 2017– 2027
5.3.1. Europe Hypoactive Sexual Desire Disorder Treatment Market, by Therapy, 2017 – 2027 (US$ Mn)
5.3.2. Europe Hypoactive Sexual Desire Disorder Treatment Market, by Country/Region, 2017 – 2027 (US$ Mn)
5.3.2.1. U.K.
5.3.2.2. Germany
5.3.2.3. Rest of Europe
5.4. Asia Pacific Hypoactive Sexual Desire Disorder Treatment Market Analysis, 2017 – 2027
5.4.1. Asia Pacific Hypoactive Sexual Desire Disorder Treatment Market, by Therapy, 2017 – 2027 (US$ Mn)
5.4.2. Asia Pacific Hypoactive Sexual Desire Disorder Treatment Market, by Country/Region, 2017 – 2027 (US$ Mn)
5.4.2.1. China
5.4.2.2. Japan
5.4.2.3. Rest of Asia Pacific...

Chapter 6. Company Profiles
6.1. AMAG Pharmaceuticals
6.1.1. Business Description
6.1.2. Financial Information (Subject to data availability)
6.1.3. Product Portfolio
6.1.4. News Coverage
6.2. Allergan, Plc.
6.3. Ivix LLX
6.4. EndoCeutics, Inc.
6.5. Emotional Brain BV ...

Browse the full report Hypoactive Sexual Desire Disorder (HSDD) Treatment Market - Growth, Future Prospects, Competitive Analysis 2019 – 2027 at https://www.credenceresearch.com/report/hypoactive-sexual-desire-disorder-hsdd-treatment-market

About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.

Contact Info:
Name: Chris Smith
Email: Send Email
Organization: Credence Research
Address: 105 N 1st ST #429, SAN JOSE, CA 95103 US
Phone: +18003618290
Website: https://www.credenceresearch.com

Source URL: https://marketersmedia.com/hypoactive-sexual-desire-disorder-hsdd-treatment-market-2019-2027-credence-research-industry-size-share-forecast/88908175

Source: MarketersMedia

Release ID: 88908175

More News From The Sport Ship

New Zealand set Sri Lanka 268 runs to win 1st test

Aug 19, 2019

GALLE, Sri Lanka — New Zealand set Sri Lanka a challenging 268-run target to win the first cricket test against Sri Lanka on Saturday after its lower order rallied around B.J Watling to salvage the team from a precarious position. The Black Caps were bowled out for 285 in their second innings after struggling on 124 for six. Watling led their resurgence, sharing a 54-run partnership with Tim Southee and adding 46 runs with William Somerville. New Zealand's tail-enders then put on 36 and 25 runs respectively for the ninth and 10th wickets. The target could prove challenging, with the...

Sri Lanka on top as New Zealand slumps to 124-6

Aug 19, 2019

GALLE, Sri Lanka — Spin bowlers Lasith Embuldeniya and Dhananjaya de Silva shared five wickets as Sri Lanka appeared in control of the first test after restricting New Zealand to 124-6 Friday at tea on Day 3. The Back Caps lead Sri Lanka by 106 runs with four second-innings wickets left. New Zealand resumed after lunch on 18-1, having earlier erased a slender 18-run deficit after dismissing Sri Lanka for 267 in its first innings. But the visitors struggled in the second session with spinners extracting more turn and bounce at Galle Stadium. Kiwi captain Kane Williamson, who failed to...

Sri Lanka's Dananjaya takes 5, New Zealand 179-5 in 1st test

Aug 19, 2019

GALLE, Sri Lanka — Sri Lanka spinner Akila Dananjaya took his fourth five-wicket haul in tests as New Zealand was restricted to 179-5 at tea on the opening day of the first test. Dananjaya had 5-50 in 18.2 overs at Galle. New Zealand resumed on 71-3 after lunch and Ross Tayor and Henry Nicolls added 100 runs for the fourth wicket. But New Zealand lost two quick wickets close to the tea break. Nicolls tried to play a sweep to Dananjaya bowling around the wicket and was given out lbw. He reviewed but television replays showed the ball was hitting...

Turkey's Erdogan witness in footballer Mesut Ozil's wedding

Aug 19, 2019

ISTANBUL — Turkey President Recep Tayyip Erdogan was in the wedding party as Arsenal midfielder Mesut Ozil tied the knot on Friday. State-run Anadolu news agency said Erdogan and his wife, Emine, were legal witnesses for Ozil, who married model, actress and former Miss Turkey Amine Gulse in Istanbul. Secular Turkish weddings require a witness each for the bride and groom. Ozil, a German player of Turkish descent, quit Germany's soccer team last year after he was criticized for posing for a photograph with Erdogan before the World Cup. In his international retirement announcement, Ozil accused the German football federation,...

Pant helps Delhi eliminate Hyderabad from IPL

Aug 19, 2019

VISAKHAPATNAM, India — Rishabh Pant hit a blistering 49 off 21 balls as Delhi Capitals notched a thrilling two-wicket victory against Sunrisers Hyderabad in the Indian Premier League Eliminator on Wednesday. Pant smashed five sixes and two fours in Delhi's first IPL play-off in six years which carried them to 165-8 when Keemo Paul struck a winning boundary on the penultimate ball of their run-chase. Hyderabad had earlier scored 162-8 despite their two key players — Englishman Jonny Bairstow and Australian David Warner — being back with their respective national teams for World Cup preparations. "If you try to stop...

About Us

We’re all about evolving the love of sports. With The Sport Ship, you can up your game and receive all the latest news about the sports world before anyone else.

Contact us: sales[at]thesportship.com

Subscribe Now!